Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,042 | 314 | 99.8% |
| Education | $13.69 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $976.22 | 25 | $0 (2024) |
| AbbVie Inc. | $562.95 | 24 | $0 (2021) |
| Amgen Inc. | $479.94 | 25 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $451.95 | 25 | $0 (2023) |
| PFIZER INC. | $388.75 | 35 | $0 (2021) |
| Merck Sharp & Dohme LLC | $364.33 | 26 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $279.55 | 13 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $238.09 | 11 | $0 (2024) |
| Allergan Inc. | $231.50 | 4 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $201.39 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $143.16 | 8 | Amgen Inc. ($57.00) |
| 2023 | $95.74 | 6 | Novo Nordisk Inc ($19.98) |
| 2022 | $49.65 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($18.65) |
| 2021 | $832.99 | 57 | AbbVie Inc. ($141.10) |
| 2020 | $682.37 | 25 | AstraZeneca Pharmaceuticals LP ($331.06) |
| 2019 | $1,409 | 68 | AstraZeneca Pharmaceuticals LP ($345.53) |
| 2018 | $1,279 | 65 | Amgen Inc. ($296.36) |
| 2017 | $1,564 | 85 | AbbVie, Inc. ($305.28) |
All Payment Transactions
317 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: DIABETES | ||||||
| 09/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Inflammation | ||||||
| 08/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Inflammation | ||||||
| 05/07/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/15/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.86 | General |
| Category: GI | ||||||
| 03/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Respiratory | ||||||
| 02/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Inflammation | ||||||
| 11/23/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: DIABETES | ||||||
| 09/11/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/25/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Inflammation | ||||||
| 08/11/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Diabetes | ||||||
| 07/13/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Oncology | ||||||
| 04/12/2023 | Merck Sharp & Dohme LLC | STEGLATRO (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/16/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: NEUROSCIENCE | ||||||
| 08/11/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Diabetes | ||||||
| 06/02/2022 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/16/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Neuromodulation | ||||||
| 08/27/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $7.29 | General |
| Category: Neuromodulation | ||||||
| 08/19/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: NEUROSCIENCE | ||||||
| 08/18/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/11/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/10/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: NEUROSCIENCE | ||||||
| 08/10/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.06 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 36 | 42 | $8,130 | $3,350 |
| 2021 | 9 | 593 | 1,109 | $107,647 | $46,918 |
| 2020 | 15 | 1,073 | 2,324 | $200,013 | $72,954 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 24 | $5,700 | $2,261 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 18 | $2,430 | $1,088 | 44.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 156 | 288 | $40,320 | $23,260 | 57.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 229 | 450 | $51,750 | $20,662 | 39.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 68 | 145 | $4,350 | $1,210 | 27.8% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2021 | 49 | 120 | $4,800 | $522.42 | 10.9% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 19 | 20 | $2,140 | $425.72 | 19.9% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 21 | 29 | $725.00 | $365.40 | 50.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 14 | 16 | $1,680 | $304.36 | 18.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 13 | 16 | $1,232 | $111.76 | 9.1% |
| 81003 | Automated urinalysis test | Office | 2021 | 24 | 25 | $650.00 | $56.25 | 8.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 366 | 956 | $109,940 | $41,537 | 37.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 155 | 251 | $35,140 | $17,735 | 50.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 71 | 129 | $13,545 | $3,372 | 24.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 119 | 320 | $9,690 | $3,120 | 32.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 32 | 32 | $5,280 | $1,412 | 26.8% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2020 | 96 | 290 | $11,740 | $1,395 | 11.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 12 | 12 | $2,100 | $1,345 | 64.1% |
| 80305 | Testing for presence of drug | Office | 2020 | 36 | 73 | $1,825 | $912.30 | 50.0% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 27 | 33 | $3,531 | $741.96 | 21.0% |
| 90674 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 27 | 27 | $675.00 | $675.00 | 100.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 19 | 21 | $1,771 | $196.69 | 11.1% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 12 | 12 | $1,205 | $176.26 | 14.6% |
| 81003 | Automated urinalysis test | Office | 2020 | 45 | 51 | $1,326 | $113.75 | 8.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 34 | 37 | $925.00 | $110.10 | 11.9% |
About Dr. Harvey Wolf, MD
Dr. Harvey Wolf, MD is a Internal Medicine healthcare provider based in Southern Pines, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215998760.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harvey Wolf, MD has received a total of $6,056 in payments from pharmaceutical and medical device companies, with $143.16 received in 2024. These payments were reported across 317 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($6,042).
As a Medicare-enrolled provider, Wolf has provided services to 1,702 Medicare beneficiaries, totaling 3,475 services with total Medicare billing of $123,222. Data is available for 3 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Southern Pines, NC
- Active Since 03/31/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1215998760
Products in Payments
- FARXIGA (Drug) $611.54
- ENTRESTO (Drug) $451.95
- VRAYLAR (Drug) $327.76
- Repatha (Biological) $186.99
- JARDIANCE (Drug) $180.24
- ELIQUIS (Drug) $167.04
- PRALUENT (Drug) $159.69
- Androgel (Drug) $154.23
- Synthroid (Drug) $152.62
- UTIBRON (Drug) $152.50
- Prolia (Biological) $139.66
- Proclaim IPG (Device) $138.67
- STEGLATRO (Drug) $127.96
- CHANTIX (Drug) $127.17
- BREZTRI AEROSPHERE (Drug) $125.00
- EUCRISA (Drug) $125.00
- NEXLIZET (Drug) $125.00
- FASENRA (Drug) $124.36
- JANUVIA (Drug) $112.00
- XARELTO (Drug) $98.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Southern Pines
Julie Baugher, M.d, M.D
Internal Medicine — Payments: $33,462
Dr. Randall Mercier, M.d, M.D
Internal Medicine — Payments: $7,107
Mr. Robert Deucher, M.d, M.D
Internal Medicine — Payments: $4,057
Thomas Jamison, Md, MD
Internal Medicine — Payments: $2,512
Michol Stanzione, Do, DO
Internal Medicine — Payments: $1,544
Dr. Loni Belyea, M.d, M.D
Internal Medicine — Payments: $1,113